Ovid Therapeutics Inc. (OVID) Operating cash flow 2016–2025
Ovid Therapeutics Inc. (OVID) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$38.3MFY2025 · since FY2016: -$17.8M → -$38.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$38.3M | +31.5% |
| FY2024 | -$56.0M | -22.2% |
| FY2023 | -$45.8M | +17.1% |
| FY2022 | -$55.2M | -146.6% |
| FY2021 | $118.6M | +329.9% |
| FY2020 | -$51.6M | -1.0% |
| FY2019 | -$51.1M | -12.1% |
| FY2018 | -$45.6M | -44.8% |
| FY2017 | -$31.5M | -76.8% |
| FY2016 | -$17.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice